bm 13505 has been researched along with thromboxane b2 in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.76) | 18.7374 |
| 1990's | 13 (76.47) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feuerstein, G; Lynch, KM; Ohlstein, EH; Poyser, R; Rabinovici, R; Sellers, TS; Slivjak, MJ; Smith, EF; Sulpizio, A; Yue, TL | 1 |
| Ishii, A; Karasawa, A; Kawakage, M; Kubo, K; Miki, I; Shirakura, S; Takeda, M | 1 |
| Horton, AA; Wood, JM | 1 |
| Neugarten, J; Schlondorff, D; Yoo, J | 1 |
| Aynedjian, HS; Bank, N; Kaplan, R; Schlondorff, D | 1 |
| Battistini, B; Filep, JG; Sirois, P | 1 |
| Besse, T; Claeys, N; Gustin, T; Lambotte, L; Schroeyers, P | 1 |
| Lefer, AM; Lefer, DJ; Mentley, RK | 1 |
| Bernheim, J; Green, J; Podjarny, E; Pomeranz, A; Rathaus, M | 1 |
| Bäcker, A; Kramer, HJ; Schwarting, K | 1 |
| Karla, W; Orr, JA; Peskar, BA; Scheid, P; Shams, H | 1 |
| Cohen, DS; Dotson, R; Mathis, J; Olson, RW; Webb, RL | 1 |
| Klimm, JL; Kloczewiak, MA; Lindon, J | 1 |
| Aoki, T; Honda, S; Okubo, M; Seki, J; Senzaki, K; Takahashi, F; Takasugi, H; Tanaka, A; Tomiyama, Y | 1 |
| Arakida, Y; Honda, K; Miyata, K; Ohga, K; Suwa, K; Yamada, T; Yokota, M | 1 |
| Gresele, P; Mezzasoma, AM; Venditti, G; Vezza, R | 1 |
| Jungermann, K; Nath, A; Pestel, S; Schieferdecker, HL | 1 |
17 other study(ies) available for bm 13505 and thromboxane b2
| Article | Year |
|---|---|
Pharmacological profile of G619, a new platelet aggregation inhibitor.
Topics: Adenosine Diphosphate; Animals; Benzamides; Calcium; Collagen; Dogs; Epinephrine; Fibrinogen; Humans; Male; Phenylacetates; Picolines; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Prostaglandin Endoperoxides, Synthetic; Rabbits; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane; Shock, Septic; Sulfonamides; Thrombin; Thromboxane B2; Vasoconstriction | 1992 |
Beneficial effect of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)ethylidene]-6,11- dihydrodibenz[b,e]oxepine-2-carboxylate monohydrate on collagen-induced coronary ischemia in guinea-pigs.
Topics: Animals; Arrhythmias, Cardiac; Benzimidazoles; Benzoxepins; Collagen; Coronary Disease; Cyclooxygenase Inhibitors; Electrocardiography; Guinea Pigs; Heart Arrest; Male; Nifedipine; Phenylacetates; Propranolol; Sulfonamides; Thromboxane A2; Thromboxane B2; Thromboxanes; Ticlopidine | 1991 |
Prevention of Ca(2+)-induced or thromboxane B2-induced hepatocyte plasma membrane bleb formation by thromboxane receptor antagonists.
Topics: Animals; Calcimycin; Calcium; Cell Death; Cell Membrane; Liver; Male; Phenylacetates; Rats; Receptors, Prostaglandin; Receptors, Thromboxane; Signal Transduction; SRS-A; Sulfonamides; Thromboxane B2 | 1991 |
Thromboxane mediates the renal hemodynamic effects of platelet activating factor.
Topics: Animals; Blood Pressure; Drug Interactions; Glomerular Filtration Rate; Hematocrit; Indomethacin; Kidney; Male; Phenylacetates; Platelet Activating Factor; Rats; Rats, Inbred Strains; Receptors, Prostaglandin; Receptors, Thromboxane; Renal Circulation; Sulfonamides; Thromboxane B2 | 1990 |
Renal vasoconstriction caused by short-term cholesterol feeding is corrected by thromboxane antagonist or probucol.
Topics: Animals; Cholesterol, Dietary; Dinoprostone; Glomerular Filtration Rate; Kidney; Lipoproteins, LDL; Male; Oxidation-Reduction; Phenylacetates; Probucol; Rats; Rats, Inbred Strains; Receptors, Prostaglandin; Receptors, Thromboxane; Renal Circulation; Saralasin; Sulfonamides; Thromboxane B2; Vasoconstriction | 1990 |
Endothelin induces thromboxane release and contraction of isolated guinea-pig airways.
Topics: Animals; Anti-Arrhythmia Agents; Bronchi; Dose-Response Relationship, Drug; Endothelins; Epoprostenol; Guinea Pigs; Lung; Male; Muscle Contraction; Muscle, Smooth; Phenylacetates; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thromboxane A2; Thromboxane B2; Thromboxanes; Trachea | 1990 |
Effect of PGI2 and thromboxane antagonist on liver ischemic injury.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Epoprostenol; Iloprost; Imidazoles; Ischemia; Liver; Male; Phenylacetates; Rats; Rats, Inbred Strains; Sulfonamides; Thromboxane B2 | 1989 |
Protective effects of a new specific thromboxane antagonist in arachidonate-induced sudden death.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Blood Pressure; Death, Sudden; Male; Phenylacetates; Platelet Count; Rabbits; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thromboxane B2; Thromboxanes | 1987 |
Adriamycin-related hypertension in pregnant rats: response to a thromboxane receptor antagonist.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Disease Models, Animal; Doxorubicin; Female; Hypertension; Phenylacetates; Pregnancy; Pregnancy Complications, Cardiovascular; Rats; Rats, Wistar; Receptors, Thromboxane; Sulfonamides; Thromboxane B2; Thromboxanes | 1995 |
Impaired renal function in obstructive jaundice: enhanced glomerular thromboxane synthesis and effects of thromboxane receptor blockade in bile duct-ligated rats.
Topics: Acute Kidney Injury; Animals; Blood Pressure; Body Weight; Cholestasis; Female; Kidney; Kidney Glomerulus; Ligation; Organ Size; Phenylacetates; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane; Sulfonamides; Thromboxane A2; Thromboxane B2 | 1995 |
Transient ventilatory responses to endotoxin infusion in the cat are mediated by thromboxane A2.
Topics: Animals; Blood Pressure; Cats; Endotoxins; Escherichia coli; Female; Hemodynamics; Indomethacin; Infusions, Intravenous; Male; Phenylacetates; Respiration; Sulfonamides; Thromboxane A2; Thromboxane B2 | 1993 |
Beneficial effects of combined thromboxane synthase inhibition/receptor blockade with CGS 22652 in a canine model of coronary thrombosis.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Caprylates; Coronary Circulation; Coronary Thrombosis; Dinoprostone; Dogs; Hemodynamics; Indoles; Male; Myocardial Reperfusion; Phenylacetates; Platelet Activation; Platelet Aggregation Inhibitors; Pyridines; Receptors, Thromboxane; Streptokinase; Sulfonamides; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes | 1993 |
Effects of free and macromolecular-bound TXA2 receptor antagonist BM 13.505 on U46619-induced platelet aggregation.
Topics: Adenosine Diphosphate; Chromatography, High Pressure Liquid; Humans; In Vitro Techniques; Phenylacetates; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Receptors, Thromboxane; Serum Albumin, Bovine; Spectrometry, Mass, Fast Atom Bombardment; Sulfonamides; Thrombin; Thromboxane B2 | 1993 |
Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
Topics: Adenosine Diphosphate; Antibodies, Monoclonal; Apyrase; Aspirin; Blood Platelets; Calcium; Cyclooxygenase Inhibitors; Dipeptides; Fibrinogen; Humans; Ion Transport; Peptide Fragments; Phenylacetates; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Thrombin; Signal Transduction; Sulfonamides; Thrombin; Thromboxane A2; Thromboxane B2; Tirofiban; Tyrosine | 1998 |
Effects of lipid mediator antagonists on predominant mediator-controlled asthmatic reactions in passively sensitized guinea pigs.
Topics: Administration, Oral; Animals; Asthma; Chromones; Disease Models, Animal; Guinea Pigs; Immunization, Passive; Leukotriene Antagonists; Leukotrienes; Male; Membrane Proteins; Phenylacetates; Receptors, Leukotriene; Receptors, Thromboxane; Serum Albumin, Bovine; Sulfonamides; Tetrazoles; Thiazoles; Thromboxane A2; Thromboxane B2 | 1999 |
Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Aspirin; Biphenyl Compounds; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Calcium Signaling; Cells, Cultured; Enzyme Inhibitors; Fatty Acids, Unsaturated; Heptanoic Acids; Humans; Hydrazines; Imidazoles; Inositol Phosphates; Kidney; Methacrylates; Phenylacetates; Platelet Activating Factor; Platelet Activation; Prostaglandin H2; Prostaglandins H; Protein Isoforms; Receptors, Thromboxane; Recombinant Fusion Proteins; Sulfonamides; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase | 2002 |
Inhibition of prostaglandin D2 clearance in rat hepatocytes by the thromboxane receptor antagonists daltroban and ifetroban and the thromboxane synthase inhibitor furegrelate.
Topics: Animals; Benzofurans; Bridged Bicyclo Compounds, Heterocyclic; Cells, Cultured; Complement C5a; Enzyme Inhibitors; Hepatocytes; Liver; Male; Metabolic Clearance Rate; Oxazoles; Perfusion; Phenylacetates; Prostaglandin D2; Rats; Rats, Wistar; Receptors, Thromboxane; Sulfonamides; Thromboxane B2; Thromboxane-A Synthase | 2003 |